ENTITY
Sino Biopharmaceutical

Sino Biopharmaceutical (1177 HK)

176
Analysis
Health CareHong Kong
Sino Biopharmaceutical Limited, through its subsidiaries, researches, develops, produces, and sells biopharmaceutical products for the medical treatment of ophthalmia, as well as modernized Chinese medicine and chemical medicine for the treatment of hepatitis.
more
Refresh
06 Feb 2015 15:02

Can Innovation labs be assessed to pick stocks for your portfolio?

Companies across different industries are building Innovation centers  in Singapore, Hong Kong and other cities across Asia and the rest of the...

Logo
679 Views
Share
05 Feb 2015 16:01

Introducing Long Term Leaders - Focussed Insights for your Core Holdings

We are pleased to announce the roll out of our latest content vertical: Long Term Leaders. Under this category,  we have identified companies that...

Logo
312 Views
Share
22 Jan 2015 07:01

Hutchison Whampoa Restructuring: Next Move for Watson's?

The announced restructuring of Cheung Kong Limited and Hutchison Whampoa Limited has been well received on the HKEx. Hutchison shares have rallied...

Share
x